Other Targets

Cat. No.

AT0656

Anti-TEM7R/PLXDC2 Antibody

The Anti-TEM7R/PLXDC2 Antibody is a human-derived monoclonal antibody produced in Chinese Hamster Ovary (CHO) cells, specifically targeting TEM7R/PLXDC2. This antibody is composed of a human IgG1 heavy chain and a human kappa light chain, and has a predicted molecular weight of 145 kDa. For experimental control purposes, the Human IgG1 kappa Isotype Control is recommended.

Cat. No.

AT0670

Anti-PLA2G1B Antibody

Cat. No.

AT0673

CAS No.

946415-13-0

FG-3019

Synonyms: Pamrevlumab; Anti-Human CTGF Recombinant Antibody

Pamrevlumab (FG-3019) is a recombinant human monoclonal antibody specifically designed to target and bind connective tissue growth factor (CTGF). This interaction is crucial for the study of idiopathic pulmonary fibrosis (IPF), providing a valuable tool for researchers investigating the pathophysiological mechanisms and potential therapeutic interventions for this condition.

Cat. No.

AT0683

CAS No.

2550297-60-2

Trosunilimab

Trosunilimab is a chimeric humanized antibody of the IgG1κ isotype, designed to specifically target ITGA4_ITGB7. For experimental control purposes, the recommended isotype control is Human IgG1 kappa.

Cat. No.

AT0692

Anti-LY6G6D Antibody (1G4)

The Anti-LY6G6D Antibody (1G4) is a humanized IgG1 monoclonal antibody specifically designed to target LY6G6D, a member of the LY6/uPAR family involved in various cellular processes. This antibody is ideal for researchers focusing on cell signaling and immune response studies. For accurate experimental control, it is recommended to use Human IgG1 kappa Isotype Control.

Cat. No.

AT0694

Anti-Hepcidin/HAMP Antibody

The Anti-Hepcidin/HAMP Antibody is a recombinant human monoclonal antibody produced in Chinese hamster ovary (CHO) cells, specifically designed to target Hepcidin, also known as HAMP. This antibody is composed of a human IgG1 heavy chain and a human lambda light chain, and exhibits a predicted molecular weight of 145 kDa. For isotype control purposes, Human IgG1 kappa, Isotype Control is recommended. This product is suitable for a range of research applications, focusing on the study of Hepcidin's role in iron metabolism and related disorders.

Cat. No.

AT0698

IMM-20059

IMM-20059 is a humanized IgG1 monoclonal antibody specifically targeting EPN1. When used in conjunction with Atezolizumab, IMM-20059 has demonstrated a significant enhancement in tumor regression within the B16.F10 syngeneic melanoma model, surpassing the efficacy observed with anti-PD-L1 monotherapy. This product is pivotal for research focused on innovative cancer treatment modalities and the exploration of synergistic therapeutic combinations.

Cat. No.

AT0709

CAS No.

372075-37-1

Sontuzumab

Synonyms: AS1402; huHMFG-1

Sontuzumab (AS1402) is a humanized IgG1κ monoclonal antibody that exhibits high specificity for the MUC1 antigen, targeting the extracellular peptide sequence PDTR with a dissociation constant (Kd) of approximately 1 nM. This antibody is primarily utilized in the research of breast cancer, providing a valuable tool for the study of MUC1-related oncogenic pathways and potential therapeutic interventions.

Cat. No.

AT0711

Anti-GPR44/PTGDR2/CD294 Antibody

Cat. No.

AT0721

CAS No.

1449294-76-1

Tomaralimab

Synonyms: OPN-305

Tomaralimab (OPN-305) is a humanized IgG4 monoclonal antibody targeting Toll-like receptor 2 (TLR2). This antibody is designed for investigational use in the study of Myelodysplastic Syndromes (MDS), offering potential insights into the role of TLR2 in the pathogenesis of this condition.

Cat. No.

AT0732

Anti-ROBO1 Antibody

The Anti-ROBO1 Antibody is a recombinant human monoclonal antibody produced in Chinese Hamster Ovary (CHO) cells. It specifically targets the Roundabout Guidance Receptor 1 (ROBO1), playing a crucial role in neural development and axonal guidance. This antibody is composed of a human IgG1 heavy chain and a human kappa light chain, with an approximate molecular weight of 150 kDa. For experimental control purposes, Human IgG1 kappa, Isotype Control is recommended.

Cat. No.

AT0743

Anti-FZD7 Antibody

The Anti-FZD7 Antibody is a human-derived monoclonal antibody produced in Chinese Hamster Ovary (CHO) cells. This antibody specifically targets the Frizzled-7 (FZD7) receptor, a member of the Frizzled family of G protein-coupled receptors involved in the Wnt signaling pathway. The antibody is composed of a human IgG1 heavy chain and a human kappa light chain, with a predicted molecular weight of 150 kDa. For isotype control purposes, Human IgG1 kappa, Isotype Control is recommended. This product is ideal for research applications focused on the study of Wnt signaling and its role in developmental processes and diseases.

Cat. No.

AT0747

Anti-TSPAN8 Antibody

The Anti-TSPAN8 Antibody is derived from human origin and produced in Chinese Hamster Ovary (CHO) cells. This antibody specifically targets the tetraspanin 8 (TSPAN8) protein. It is composed of a human IgG1 heavy chain and a human kappa light chain, with an approximate molecular weight of 150 kDa. For isotype control, the Human IgG1 kappa, Isotype Control is recommended. This antibody is suitable for a variety of research applications focusing on the role of TSPAN8 in cellular processes and disease mechanisms.

Cat. No.

AT0750

CAS No.

2516243-54-0

Adintrevimab

Synonyms: ADG 20

Adintrevimab (ADG 20) is a human IgG1 monoclonal antibody specifically targeting the SARS-CoV (SARS-CoV) virus. This antibody demonstrates inhibitory activity against SARS-CoV-2 variants as well as other SARS-like coronaviruses that possess pandemic potential. This makes it a valuable tool for research into the prevention and treatment of current and future coronavirus outbreaks.

Cat. No.

AT0759

CAS No.

2413817-97-5

Gresonitamab

Synonyms: AMG 910; Anti-Human CD3xClaudin18 2

Gresonitamab (AMG 910) is a half-life extended bispecific T-cell engager (BiTE) antibody designed to target CD3-positive T cells and tumor cells expressing CLDN18.2. This antibody facilitates the engagement and activation of T cells at tumor sites, enhancing the immune response against cancer cells. Gresonitamab is primarily utilized in research focused on adenocarcinoma, providing a valuable tool for investigating immune-based therapeutic strategies in this cancer type.

Cat. No.

AT0760

CAS No.

2456307-11-0

Umesolerbart

Umesolerbart (REGN5714) is a monoclonal antibody specifically targeting Bet v1, a major allergen from birch trees. This antibody exhibits cross-reactivity with homologous allergens found in alder, hazel, and hornbeam, making it an invaluable tool for studying cross-reactivity patterns in tree pollen allergies. Umesolerbart (REGN5714) is ideal for research applications focused on allergen characterization and the development of therapeutic strategies for pollen-induced allergic responses.

Cat. No.

AT0764

Anti-GC1q R/C1QBP Antibody (60.11)

The Anti-GC1q R/C1QBP Antibody (60.11) is a chimeric mouse monoclonal antibody of the IgG1, κ subclass, specifically designed to target human GC1q R/C1QBP. For accurate experimental control, it is recommended to use Mouse IgG1 kappa Isotype Control alongside this antibody.

Cat. No.

AT0769

TOL-101

TOL-101 is a monoclonal antibody that specifically targets the T-cell receptor (TCR). This antibody is designed for use in the study of T-cell mediated immune responses and may be utilized in various immunological assays to investigate TCR function and expression. TOL-101 is valuable for researchers focusing on cellular immunology, autoimmunity, and the development of immunotherapies.

Cat. No.

AT0774

CAS No.

2460809-80-5

Burfiralimab

Synonyms: hzVSF-v13

Burfiralimab (hzVSF-v13) is a monoclonal IgG4 antibody targeting vimentin present on the surface of virus-infected cells. It exhibits broad-spectrum antiviral activity and possesses anti-inflammatory properties, specifically mitigating virus-induced inflammation. This antibody is particularly relevant for research focused on severe COVID-19, providing a critical tool for studies aimed at understanding and potentially mitigating the impact of viral infections.

Cat. No.

AT0775

CAS No.

1587257-96-2

CDX-1401

Synonyms: Rasdegafusp alfa

CDX-1401 is a recombinant human monoclonal antibody produced in Chinese Hamster Ovary (CHO) cells. It specifically targets LY75/CD205/DEC-205, a receptor involved in antigen capture and presentation. This antibody is composed of a human IgG1 heavy chain and a human kappa light chain, with an approximate molecular weight of 145 kDa. For experimental control purposes, the appropriate isotype control is Human IgG1 kappa.

Cat. No.

AT0778

CAS No.

2641646-59-3

Paridiprubart

Synonyms: NI-0101

Paridiprubart (NI-0101) is a humanized monoclonal antibody that targets Toll-like receptor 4 (TLR4). This antibody has been developed for potential application in the research of rheumatoid arthritis, focusing on its role in modulating immune responses associated with the disease. Paridiprubart offers a valuable tool for investigating the pathophysiological mechanisms and therapeutic interventions for rheumatoid arthritis through its specific interaction with TLR4.

Cat. No.

AT0783

Anti-TLR3/CD283 Antibody (CNTO5429)

Synonyms: CNTO5429

The Anti-TLR3/CD283 Antibody (CNTO5429) is a recombinant human antibody produced in Chinese Hamster Ovary (CHO) cells. It specifically targets TLR3/CD283, a receptor involved in the innate immune response to viral double-stranded RNA. This antibody comprises a human IgG2 heavy chain and a human kappa light chain, and exhibits a predicted molecular weight of 145.42 kDa. For experimental control purposes, the recommended isotype control is Human IgG4 kappa.

Cat. No.

AT0791

Anti-Matriptase Antibody

The Anti-Matriptase Antibody is a human-derived monoclonal antibody, expressed in Chinese Hamster Ovary (CHO) cells, specifically targeting Matriptase. This antibody is comprised of a human IgG1 heavy chain and a human kappa light chain, with an approximate molecular weight of 150 kDa. For experimental control purposes, the Human IgG1 kappa, Isotype Control serves as the appropriate isotype control for this antibody. This product is ideal for research applications focusing on the biological role and pathological significance of Matriptase.

Cat. No.

AT0795

CAS No.

2135632-29-8

Atoltivimab

Synonyms: REGN3470

Atoltivimab (REGN3470), also known as maftivimab/odesivimab under the brand name Inmazeb, is distinguished as the first monoclonal antibody approved by the U.S. Food and Drug Administration (FDA) for targeting Zaire ebolavirus (EBOV) infections. This therapeutic agent is specifically designed to neutralize the virus, providing a critical tool in the management and treatment of Ebola virus disease.

Cat. No.

AT0796

Anti-Dectin-1 Antibody (2M24)

The Anti-Dectin-1 Antibody (2M24) is a humanized IgG1 monoclonal antibody specifically designed to target Dectin-1, a key receptor involved in the recognition of β-glucans on pathogens, thereby playing a crucial role in the immune response against fungal infections. For accurate experimental control, it is recommended to use Human IgG1 kappa as an isotype control. This antibody is ideal for use in research focused on immune system responses, particularly in the study of fungal pathogenesis and innate immunity.